Tag: pharmaceuticals

The staggering cost of orphan drugs in the United States

Turing Pharmaceuticals faced public outrage after the company’s CEO, Martin Shkreli, raised the price of the drug Daraprim by over 5,000 percent.     Daraprim helps treat toxoplasmosis, which can be a dangerous disease to people with weak immune systems. Turing Pharmaceuticals purchased Daraprim from Impax Laboratories for $55 million in August and quickly increased the… Read More